Cargando…
Lessons from the failure of the adenovector HIV vaccine
The much-publicised halting of the joint Merck/HIV Vaccine Trials Network phase IIB candidate HIV-1 vaccine trial in 2007 has led to an unprecedented degree of discussion and introspection amongst the HIV research community. In this commentary, we will summarise the lessons learned from the trial an...
Autores principales: | Blais, Marie-Eve, Rowland-Jones, Sarah |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Biology Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924706/ https://www.ncbi.nlm.nih.gov/pubmed/20948634 http://dx.doi.org/10.3410/B1-50 |
Ejemplares similares
-
Alternate serotype adenovector provides long-term therapeutic gene expression in the eye
por: Hamilton, Melissa M., et al.
Publicado: (2008) -
Adenovector GAD65 gene delivery into the rat trigeminal ganglion produces orofacial analgesia
por: Vit, Jean-Philippe, et al.
Publicado: (2009) -
Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels
por: Tiemessen, Machteld M., et al.
Publicado: (2022) -
Biodistribution and residence time of adenovector serotype 5 in normal and immunodeficient mice and rats detected with bioluminescent imaging
por: Liu, Qiang, et al.
Publicado: (2017) -
Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations
por: Salisch, N. C., et al.
Publicado: (2019)